In the News

Sheaff Brock In The News

Sheaff Brock is making news in the investment industry. Dave Gilreath, Managing Partner and Chief Investment Officer, is a contributor of investment commentary and perspectives to a variety of financial publications, including CNBCMedical EconomicsThinkAdvisor, and Financial Advisor Magazine.

Click on the text links below to access our latest feature stories.

Sheaff Brock in the news, Dave Gilreath publications for Medical Economics, photo from the bottom of a staircase looking up at a person climbing the stairs with their dog on a leash

9 Reasons the Bull Market Will Continue

June 5, 2024 | Commentary by David Gilreath | Medical Economics

The market has delivered a parade of new highs for major indexes in 2024, but investors may be wondering whether it’s time to cash out before the market declines. Managing Director Dave Gilreath is here to share 9 reasons to believe that the market will perform well for the rest of 2024 and at least early into 2025. Read on in his latest Medical Economics article.

Read more +

Sheaff Brock in the news, Dave Gilreath publications for Medical Economics, silhouette of a person letting go of a rope swing above a lake

Volatility Will Hurt Stock Returns Only If You Let It

May 9, 2024 | Commentary by David Gilreath | Medical Economics

Volatility gives investors the heebie jeebies for fear of damaging stock portfolios, but volatility isn’t actually the problem—investors’ reaction to volatility is. Managing Director Dave Gilreath talks about how volatility is widely misunderstood, as well as what volatility actually is and isn’t in his latest article for Medical Economics.

Read more +

Sheaff Brock in the news, Dave Gilreath publications for CNBC, close-up of tabletop model of anatomical heart

Op-ed: Here Are 6 Health-care Stocks to Watch Now, Amid a Bumpy Recovery

April 24, 2024 | Commentary by David Gilreath | CNBC

After a couple of lower-performing years, the healthcare market sector has recovered over the past six months with the potential to continue improving. With this upturn, Managing Director Dave Gilreath shares six healthcare stocks to consider in his latest article for CNBC.

Read more +

Sheaff Brock in the news, Dave Gilreath publications for Financial Advisor, close-up of blank notebook and calculator on top of pile of 5 and 20 dollar bills

History's Clues To The Post-Rate-Cut Market

April 23, 2024 | Commentary by David Gilreath | Financial Advisor

Many advisors today seem to assume that lower federal funds rates will be a magic solution for the market. But just how much of a positive impact should really be expected, and for how long? Managing Director Dave Gilreath shares his thoughts in his latest Financial Advisor article.

Read more +

Sheaff Brock in the news, Dave Gilreath publications for Medical Economics, close-up of open notebook with hand setting pen on the page

History’s Clues for Market Performance in 2024

April 5, 2024 | Commentary by David Gilreath | Medical Economics

As of April, the S&P 500 has hit 22 new highs this year. But when should we expect the market to start to descend? Managing Director Dave Gilreath says in his latest Medical Economics article that, while we can’t exactly predict when the next downturn will be, we can look back through market history to get a sense of historical patterns that might repeat.

Read more +

Sheaff Brock in the news, Dave Gilreath publications for Medical Economics, laptop and tablet on a desk with plants and papers around them

Productivity: The Secret Sauce of the Economy

March 25, 2024 | Commentary by David Gilreath | Medical Economics

Typically, with an upswing in the market also comes an increase in inflation. But right now, we’re experiencing a decrease in inflation. Why? Economic productivity is a likely candidate, according to Managing Director Dave Gilreath in his latest Medical Economics article.

Read more +

Sheaff Brock in the news, Dave Gilreath JR Humphreys publications for Medical Economics, close-up photo of brightly colored Legos stacked on top of each other

Preferred Stocks: Superior Income And Now Growth

March 21, 2024 | Commentary by David Gilreath & JR Humphreys | Financial Advisor

Elevated bond yields have advisors thinking about adding more bonds into their portfolios. And that certainly is an option, but according to Managing Director Dave Gilreath and Senior Portfolio Manager JR Humphreys, so is adding preferred stocks instead, which are experiencing their own growth spurt.

Read more +

Sheaff Brock in the news, Dave Gilreath publications for Medical Economics, close-up photo of the undersides of green, leafy plants

One Key Market Sector Likely to Grow in 2024

January 31, 2024 | Commentary by David Gilreath | Medical Economics

What market sectors do you think will grow in 2024? Managing Director Dave Gilreath shares his thoughts in his latest article for Medical Economics.

Read more +

Sheaff Brock in the news, Dave Gilreath publications for Medical Economics, round paper lanterns lit up at night

Evaluating the Risks of Investing in Chinese Stocks

January 30, 2024 | Commentary by David Gilreath | Medical Economics

American investors have long been investing in Chinese stocks, despite the fact that they haven’t typically produced positive returns. Managing Director Dave Gilreath dives into this investing phenomenon by assessing the current risks of investing in Chinese stocks.

Read more +

Sheaff Brock in the news, Dave Gilreath publications for ThinkAdvisor, view of a man sitting down at a cafe table from behind

Getting Clients to Buy Into the Return to Normalcy

January 24, 2024 | Commentary by David Gilreath | ThinkAdvisor

The past four years have been filled with twists and turns on the economic rollercoaster, but a return to normalcy seems to be on the horizon. However, some advisors and investors are still feeling cautious. Read on for Managing Director Dave Gilreath‘s take.

Read more +

Sheaff Brock in the news, Dave Gilreath publications for Financial Advisor, large metal tangent pole with electrical wires running across with a yellow-green gradient background

Utilities: Unsexy But Highly Stable, With Reliable Dividends

December 29, 2023 | Commentary by David Gilreath | Financial Advisor

Utilities may not be the sexiest stock to own, but they make up for it with their potentially reliable dividends. Managing Partner Dave Gilreath discusses this and more in his latest Financial Advisor article.

Read more +

Sheaff Brock in the news, Dave Gilreath publications for Medical Economics, aerial view of waves crashing on the beach and the receding tide

The Inevitable Rise and Fall of Market Sectors

December 20, 2023 | Commentary by David Gilreath | Medical Economics

In his latest Medical Economics article, Managing Partner Dave Gilreath posits that similarities to Newton’s universal law of gravitation can be seen in the stock market with the rise and fall of stock sectors.

Read more +

Sheaff Brock in the news, Dave Gilreath publications for CNBC, close-up and abstracted view of light from a sparkler

Sheaff Brock Lands A Top Ten Spot In CNBC's FA 100 Ranking

December 19, 2023 | Benzinga

Sheaff Brock received incredible news in the last half of 2023! Want to know what it was? Benzinga wrote all about it in their latest article.

Read more +

Sheaff Brock in the news, Dave Gilreath publications for CNBC, close-up of a skeleton key in a lock

With Continued Geopolitical Conflicts, Here Are Defense Stocks Investors Should Consider

December 1, 2023 | Commentary by David Gilreath | CNBC

During times of geopolitical conflict, it’s natural that investors may think about defense stocks. In his latest CNBC article, Managing Director Dave Gilreath analyzes a variety of defense companies and stocks for investors to consider.

Read more +

Sheaff Brock in the news, Dave Gilreath publications for Medical Economics, symmetrical 6-story apartment buildings with brick and white facades

Indirect, Angst-Free Ways To Invest In Real Estate

November 30, 2023 | Commentary by David Gilreath | Medical Economics

Investing in real estate can possibly result in long-term gain, but at what price? Sheaff Brock’s Managing Partner Dave Gilreath breaks down indirect ways to invest in real estate in his latest Medical Economics article for those looking to dive in.

Read more +

Sheaff Brock in the news, Dave Gilreath publications for ThinkAdvisor, bottle of hand sanitizer on a shelf with a plant

Do Your Clients Suffer From Infectious Doomsday Syndrome?

November 13, 2023 | Commentary by David Gilreath | ThinkAdvisor

Have you heard of Infectious Doomsday Syndrome (IDS)? Learn how it may be impacting your investments in a recent ThinkAdvisor article by Sheaff Brock’s Managing Partner Dave Gilreath.

Read more +

Sheaff Brock in the news, Dave Gilreath publications for Medical Economics

Stocks vs. Bonds: There's No Contest

October 9, 2023 | Commentary by David Gilreath | Medical Economics

In Managing Director Dave Gilreath’s latest article with Medical Economics, he considers key distinctions between stocks and bonds and details why discipline and patience are critical for successful stock investing.

Read more +

Sheaff Brock in the news, Dave Gilreath publications for Medical Economics, far-off shot of a person standing on a sand dune with a trail of footprints in the sand

2023: The Terrible Financial Year That Isn’t

August 31, 2023 | Commentary by David Gilreath | Medical Economics

After more than half a year of doomsday forecasts for the 2023 stock market, Managing Director Dave Gilreath says it may turn out to be the terrible financial year that wasn’t. In this Medical Economics article, he looks back at the year so far and analyzes how the market is doing and where it may go next.

Read more +

Sheaff Brock in the news, Dave Gilreath publications for Medical Economics

The Negative Outlook on REITs is Overblown

August 30, 2023 | Commentary by David Gilreath & JR Humphreys | Medical Economics

2023 has brought some fears surrounding REITs due to rising interest rates pushing up the costs of financing property purchases. However, these fears have turned out to be overblown as the Federal Reserve’s interest rate-hiking cycle is winding down.

Read more +

Sheaff Brock in the news, Sheaff Brock commentary for The Portfolio Playbook

Helping You Help Your Clients: Learn How To Craft Your Investment Portfolio

August 24, 2023 | Interview with David Gilreath & Ron Brock | The Portfolio Playbook (Ep. 2)

Listen to Managing Directors Dave Gilreath and Ron Brock on “The Portfolio Playbook” podcast, where they discuss the process of building their own registered investment advisory business and share innovative company growth strategies for other RIAs.

Listen to the podcast +

Sheaff Brock in the news, Dave Gilreath publications for Medical Economics, shot from inside a dome looking up at metal joints and crossbeams

Investing Intelligence: Is There Growth To Be Found In The Building Materials Sectors?

July 31, 2023 | Commentary by David Gilreath | Medical Economics

Managing Director Dave Gilreath explores the building materials sectors and whether there is potential growth to be had there, particularly as the market shifts from a bear market to an embryonic bull market.

Read more +

Sheaff Brock in the news, Sheaff Brock news with Cboe Global Markets

Celebrating One Year of Innovative Portfolios ETFs at Cboe Global Markets

July 30, 2023 | Interview with David Gilreath & Ron Brock | Cboe Global Markets

Managing Directors Dave Gilreath and Ron Brock sit down for an interview with Rick Rosenthal, Director of North American Derivative Sales at Cboe Global Markets, to reflect on the first anniversary of their two ETFs at Innovative Portfolios, Sheaff Brock’s affiliate company.

Watch the interview +

Sheaff Brock in the news, Dave Gilreath publications for Medical Economics

The Building Blocks of Industry and Construction

July 21, 2023 | Commentary by David Gilreath | Medical Economics

As Managing Director Dave Gilreath mentions in this month’s Medical Economics article, demand for manufacturing and construction materials is increasing, signaling distinct growth potential for this small but important sector.

Read more +

Sheaff Brock in the news, Dave Gilreath publications for CNBC

Op-ed: Here's a Midyear Stock-Picking Guide for both Bears and Bulls Amid Recession Debate

June 23, 2023 | Commentary by David Gilreath | CNBC

In this month’s article for CNBC, Managing Partner Dave Gilreath discusses some of the best sectors for recession disbelievers to invest in such as industrials, materials and financials.

Read more +

DISCLAIMER

Sheaff Brock Investment Advisors, LLC (“SBIA”) is an SEC-registered investment advisor founded in 2001. Clients or prospective clients are directed to SBIA’s Form ADV Part 2A prior to deciding to participate in any portfolio or making any investment decision. The views and opinions in the preceding commentary are subject to change without notice and are as of the date of the report. There is no guarantee that any market forecast set forth in the commentary will be realized. This material represents an assessment of the market environment at a specific point in time, should not be relied upon as investment advice, and is not intended to predict or depict performance of any investment. Any specific recommendations or comparisons that are made as to particular securities or strategies are for illustrative purposes only and are not meant as investment advice for any viewer. The companies mentioned in the publications may be held by Sheaff Brock Investment Advisors, Innovative Portfolios, Innovative Portfolios’ ETFs or any other affiliates or related persons. Therefore, there is a conflict of interest that the advisors may have a vested interest in the Companies and the statements made about them. Past performance does not guarantee or indicate future results.